Comorbidity Patterns in Inflammatory Bowel Disease: Insights from All of Us
Overview
This study of 5,094 inflammatory bowel disease (IBD) patients from the diverse All of Us Research Program identified 22 significant comorbidities across seven organ systems. Novel associations such as delayed postmyocardial infarction pericarditis, contact dermatitis, and carotid artery aneurysms were discovered, highlighting IBD as a multisystem disorder.
Background
Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, affects millions worldwide with rising prevalence and substantial healthcare costs. Beyond gastrointestinal symptoms, IBD is associated with a broad range of comorbidities that complicate management and worsen outcomes. Prior research has been limited by predominantly White European cohorts, underrepresenting racial minorities and rare comorbidities. The All of Us Research Program provides a demographically diverse dataset to comprehensively investigate IBD comorbidities across multiple organ systems.
Data Highlights
The study analyzed 5,094 IBD cases matched 1:4 with controls by age, gender, and race. A total of 22 significant comorbidities were identified spanning seven organ systems. Novel associations included delayed postmyocardial infarction pericarditis, contact dermatitis, and carotid artery aneurysms. The cohort was more diverse than traditional studies, with 70% White participants and 77% from historically underrepresented groups.
Key Findings
IBD patients exhibited 22 significant comorbidities across dermatologic, cardiovascular, autoimmune, and other systemic categories.
Novel comorbidity associations identified include delayed postmyocardial infarction pericarditis, contact dermatitis, and carotid artery aneurysms.
The study cohort was demographically diverse, addressing limitations of prior predominantly White European cohorts.
Systemic inflammation and epithelial barrier dysfunction likely contribute to multisystem involvement in IBD.
Validated case definitions combining diagnostic codes and medication data enhanced accuracy of IBD identification.
Clinical Implications
Clinicians should recognize IBD as a multisystem disorder with diverse comorbidities beyond the gastrointestinal tract, necessitating comprehensive screening and management strategies. Awareness of rare cardiovascular and dermatologic comorbidities may improve patient outcomes. Utilizing diverse population data can better inform personalized care for underrepresented groups.
Conclusion
This large, diverse study expands understanding of IBD comorbidities, revealing novel systemic associations and reinforcing the need for holistic management approaches. Future research should continue leveraging diverse cohorts to refine surveillance and therapeutic strategies.
References
All of Us Research Program -- Nationwide Precision Medicine Initiative
IBD Epidemiology and Economic Burden Studies -- Various Sources
SPARC IBD and TARGET-IBD Cohort Demographics -- Prior Publications
